FDA, Congress Spur Pediatric Drug Development
Sponsors are underwriting more studies of children, but controversy continues over the need for FDA’s pediatric rule and the impact of extended exclusivity on generics.
For full article Click Here
Journal:
Applied Clinical Trials, Jul 1, 2002.
Copyright:
©Advanstar Communications, Inc. All rights reserved.